Sonographic Features of Inflammatory Breast Cancer

Le-Petross, Huong; Uppendahl, Locke; Stafford, Jason

doi:10.1053/j.ro.2011.04.003

Cited by 9 publications

(3 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The incidence of axillary lymphadenopathy in our study (76%) is lower than the 93% noted by Yang et al . However, in our series, we also found that ultrasound was useful for the detection of supraclavicular, infraclavicular and internal mammary lymph nodes (Fig.…”

Section: Discussioncontrasting

confidence: 48%

Review of ultrasound appearance in inflammatory breast cancer: A pictorial essay

et al. 2015

View full text Add to dashboard Cite

Inflammatory breast cancer (IBC) is a rare malignancy accounting for 1-2% of breast cancers. It has an aggressive clinical presentation and poor prognosis. The sonographic findings in 41 patients with a clinical diagnosis of IBC and biopsy-proven breast malignancy are presented in this study. The most common finding was the presence of skin thickening (92%). Multiple small anechoic spaces within the dermis, correlating with the presence of dermal lymphatic invasion by tumour emboli on histopathology were noted in approximately one-third of cases. Other sonographic findings included single or multiple masses, parenchymal oedema, axillary lymphadenopathy, echogenic foci consistent with microcalcifications and increased vascularity.

show abstract

Section: Discussioncontrasting

confidence: 48%

Review of ultrasound appearance in inflammatory breast cancer: A pictorial essay

et al. 2015

View full text Add to dashboard Cite

show abstract

“…The utility of bilateral breast imaging to assess both bilateral breast cancer at presentation or cross lymphatic metastasis to the contralateral breast or nodal basin was described, owing to the prevalence of contralateral breast cancer in up to 5% of IBC patients at 2 years compared with approximately 1.1% at 2 years for non-IBC patients 7 . Relevant ultrasound findings include skin thickening, a breast mass or diffuse abnormal non-mass hypoechoic tissue with posterior acoustic shadowing, hyperechoic foci representing calcifications, and nodal disease 5 , 8 , 9 . If a primary breast lesion (mass or non-mass lesion) can be identified by ultrasound, then a core biopsy of the primary breast lesion and fine needle aspiration or core biopsy of suspicious axillary or infra/supraclavicular lymph node(s) should be performed 5 , 10 .…”

Section: Introductionmentioning

confidence: 99%

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference

Ueno¹,

Fernandez²,

Cristofanilli³

et al. 2018

J. Cancer

View full text Add to dashboard Cite

National and international experts in inflammatory breast cancer (IBC) from high-volume centers treating IBC recently convened at the 10th Anniversary Conference of the Morgan Welch Inflammatory Breast Cancer Research Program at The University of Texas MD Anderson Cancer Center in Houston Texas. A consensus on the clinical management of patients with IBC was discussed, summarized, and subsequently reviewed. All participants at the conference (patients, advocates, researchers, trainees, and clinicians) were queried using the MDRing electronic survey on key management issues. A summary of the expert consensus and participant voting is presented. Bilateral breast and nodal evaluation, breast magnetic resonance imaging, positron emission tomography/computed tomography, and medical photographs were endorsed as optimal. Neoadjuvant systemic therapy, modified radical mastectomy and level I and II ipsilateral axillary node dissection, post-mastectomy radiotherapy, adjuvant targeted therapy and hormonal therapy as indicated, and delayed reconstruction were agreed-upon fundamental premises of standard non-protocol-based treatment for IBC. Consideration for local-regional therapy in de novo stage IV IBC was endorsed to provide local control whenever feasible. Variation across centers and special circumstances were discussed.

show abstract

“…H Carisa Le-Petross (MD Anderson Cancer Center, Houston, Texas, USA) discussed assessment of residual disease in IBC patients who received neoadjuvant chemotherapy, using mammography, ultrasound, and magnetic resonance imaging. The work determined that both ultrasound and magnetic resonance imaging are effective in determining residual disease in patients [14,15]. …”

Section: Meeting Sessionsmentioning

confidence: 99%